S

Sunzen Biotech Bhd
KLSE:SUNZEN

Watchlist Manager
Sunzen Biotech Bhd
KLSE:SUNZEN
Watchlist
Price: 0.31 MYR
Market Cap: 249.5m MYR
Have any thoughts about
Sunzen Biotech Bhd?
Write Note

Sunzen Biotech Bhd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sunzen Biotech Bhd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Sunzen Biotech Bhd
KLSE:SUNZEN
Cost of Revenue
-myr104.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Dswiss Inc
OTC:DQWS
Cost of Revenue
-$1.9m
CAGR 3-Years
-17%
CAGR 5-Years
-85%
CAGR 10-Years
N/A
E
Eng Kah Corporation Bhd
KLSE:ENGKAH
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Karex Bhd
KLSE:KAREX
Cost of Revenue
-myr338.8m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Cost of Revenue
-myr57.7m
CAGR 3-Years
10%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
No Stocks Found

Sunzen Biotech Bhd
Glance View

Market Cap
249.5m MYR
Industry
Consumer products

Sunzen Biotech Bhd.is an investment holding company, which engages in biotechnology research and development, and the manufacture and marketing of animal feed supplement products. The company is headquartered in Shah Alam, Selangor. The company went IPO on 2008-10-08. Its segments include Manufacturing and trading of animal health products (AH), Trading of crude palm oil products (CPO), Traditional Chinese medicines, herbal foods and beverages, bird's nest (TCM) and Loan financing. The company specializes in animal health and nutrition, manufactures and markets a range of related products for both livestock and companion animals. The company is also involved in the palm oil trading business, which entails the trading of crude palm oil and its derivative products. Its product categories include feed additive, oral pump, functional red palm oil, injectables, water soluble, detergent and disinfection and premix. Its animal health products are offered to domestic and overseas markets in countries, such as China, Korea and the Middle East.

SUNZEN Intrinsic Value
0.22 MYR
Overvaluation 28%
Intrinsic Value
Price
S

See Also

What is Sunzen Biotech Bhd's Cost of Revenue?
Cost of Revenue
-104.4m MYR

Based on the financial report for Jun 30, 2024, Sunzen Biotech Bhd's Cost of Revenue amounts to -104.4m MYR.

Back to Top